METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION
AssigneeCurium US LLC
InventorsAmanda Donovan, Lauren Radford, Allan Casciola
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method of detecting prostate cancer in a human subject wherein the human subject is administrated about 7 mCi to about 9 mCi of a Cu-64 PSMA I&T composition, images are obtained between 1 and 4 hours post administration, and wherein the images obtained retain acceptable image quality up to 4 hours post dose.
Claims25
A method of detecting prostate cancer in a patient in need thereof, comprising the steps of:
- (a) administering to the patient about 5 mCi to about 9 mCi of a Cu-64 PSMA I&T composition, and
- (b) imaging the patient between about 1 hour 15 minutes to about 4 hours 30 minutes post administration of the composition,
- wherein the image is of acceptable image quality.
A method of detecting prostate cancer in a patient in need thereof, comprising the steps of:
- (a) administering to the patient about 7 mCi to about 9 mCi of a Cu-64 PSMA I&T composition, and
- (b) imaging the patient up to 4.5 hours after administration of the composition;
- wherein the resulting image allows a reader to detect prostate cancer in the patient.
A method of detecting prostate cancer in a patient in need thereof, comprising the steps of:
- (a) administering to the patient about 5 mCi to about 9 mCi of a Cu-64 PSMA I&T composition, and
- (b) imaging the patient between about 1 hour to about 4 hours post administration of the composition,
- wherein the resulting image does not produce a correct detection rate below 80%.
Dependencies are inferred from the claim text.